Table of Contents

2019-2024 Global Neuromyelitis Optica Drug Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neuromyelitis Optica Drug Consumption 2014-2024
2.1.2 Neuromyelitis Optica Drug Consumption CAGR by Region
2.2 Neuromyelitis Optica Drug Segment by Type
2.2.1 Glucocorticoids
2.2.2 Immunoglobulin
2.3 Neuromyelitis Optica Drug Consumption by Type
2.3.1 Global Neuromyelitis Optica Drug Consumption Market Share by Type (2014-2019)
2.3.2 Global Neuromyelitis Optica Drug Revenue and Market Share by Type (2014-2019)
2.3.3 Global Neuromyelitis Optica Drug Sale Price by Type (2014-2019)
2.4 Neuromyelitis Optica Drug Segment by Application
2.4.1 Acute attack
2.4.2 Remission prophylactic treatment
2.5 Neuromyelitis Optica Drug Consumption by Application
2.5.1 Global Neuromyelitis Optica Drug Consumption Market Share by Application (2014-2019)
2.5.2 Global Neuromyelitis Optica Drug Value and Market Share by Application (2014-2019)
2.5.3 Global Neuromyelitis Optica Drug Sale Price by Application (2014-2019)

3 Global Neuromyelitis Optica Drug by Players
3.1 Global Neuromyelitis Optica Drug Sales Market Share by Players
3.1.1 Global Neuromyelitis Optica Drug Sales by Players (2017-2019)
3.1.2 Global Neuromyelitis Optica Drug Sales Market Share by Players (2017-2019)
3.2 Global Neuromyelitis Optica Drug Revenue Market Share by Players
3.2.1 Global Neuromyelitis Optica Drug Revenue by Players (2017-2019)
3.2.2 Global Neuromyelitis Optica Drug Revenue Market Share by Players (2017-2019)
3.3 Global Neuromyelitis Optica Drug Sale Price by Players
3.4 Global Neuromyelitis Optica Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Neuromyelitis Optica Drug Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Neuromyelitis Optica Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers and Acquisitions, Expansion

4 Neuromyelitis Optica Drug by Regions
4.1 Neuromyelitis Optica Drug by Regions
4.1.1 Global Neuromyelitis Optica Drug Consumption by Regions
4.1.2 Global Neuromyelitis Optica Drug Value by Regions
4.2 Americas Neuromyelitis Optica Drug Consumption Growth
4.3 APAC Neuromyelitis Optica Drug Consumption Growth
4.4 Europe Neuromyelitis Optica Drug Consumption Growth
4.5 Middle East and Africa Neuromyelitis Optica Drug Consumption Growth

5 Americas
5.1 Americas Neuromyelitis Optica Drug Consumption by Countries
5.1.1 Americas Neuromyelitis Optica Drug Consumption by Countries (2014-2019)
5.1.2 Americas Neuromyelitis Optica Drug Value by Countries (2014-2019)
5.2 Americas Neuromyelitis Optica Drug Consumption by Type
5.3 Americas Neuromyelitis Optica Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Neuromyelitis Optica Drug Consumption by Countries
6.1.1 APAC Neuromyelitis Optica Drug Consumption by Countries (2014-2019)
6.1.2 APAC Neuromyelitis Optica Drug Value by Countries (2014-2019)
6.2 APAC Neuromyelitis Optica Drug Consumption by Type
6.3 APAC Neuromyelitis Optica Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Neuromyelitis Optica Drug by Countries
7.1.1 Europe Neuromyelitis Optica Drug Consumption by Countries (2014-2019)
7.1.2 Europe Neuromyelitis Optica Drug Value by Countries (2014-2019)
7.2 Europe Neuromyelitis Optica Drug Consumption by Type
7.3 Europe Neuromyelitis Optica Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East and Africa
8.1 Middle East and Africa Neuromyelitis Optica Drug by Countries
8.1.1 Middle East and Africa Neuromyelitis Optica Drug Consumption by Countries (2014-2019)
8.1.2 Middle East and Africa Neuromyelitis Optica Drug Value by Countries (2014-2019)
8.2 Middle East and Africa Neuromyelitis Optica Drug Consumption by Type
8.3 Middle East and Africa Neuromyelitis Optica Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Neuromyelitis Optica Drug Distributors
10.3 Neuromyelitis Optica Drug Customer

11 Global Neuromyelitis Optica Drug Market Forecast
11.1 Global Neuromyelitis Optica Drug Consumption Forecast (2019-2024)
11.2 Global Neuromyelitis Optica Drug Forecast by Regions
11.2.1 Global Neuromyelitis Optica Drug Forecast by Regions (2019-2024)
11.2.2 Global Neuromyelitis Optica Drug Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East and Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East and Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Neuromyelitis Optica Drug Forecast by Type
11.8 Global Neuromyelitis Optica Drug Forecast by Application

12 Key Players Analysis
12.1 Pfizer
12.1.1 Company Details
12.1.2 Neuromyelitis Optica Drug Product Offered
12.1.3 Pfizer Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Pfizer News
12.2 FRESENIUS
12.2.1 Company Details
12.2.2 Neuromyelitis Optica Drug Product Offered
12.2.3 FRESENIUS Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 FRESENIUS News
12.3 TEVA
12.3.1 Company Details
12.3.2 Neuromyelitis Optica Drug Product Offered
12.3.3 TEVA Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 TEVA News
12.4 SANDOZ
12.4.1 Company Details
12.4.2 Neuromyelitis Optica Drug Product Offered
12.4.3 SANDOZ Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 SANDOZ News
12.5 Intas
12.5.1 Company Details
12.5.2 Neuromyelitis Optica Drug Product Offered
12.5.3 Intas Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Intas News
12.6 Gyjtrs
12.6.1 Company Details
12.6.2 Neuromyelitis Optica Drug Product Offered
12.6.3 Gyjtrs Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Gyjtrs News
12.7 NANG KUANG
12.7.1 Company Details
12.7.2 Neuromyelitis Optica Drug Product Offered
12.7.3 NANG KUANG Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 NANG KUANG News
12.8 Tianjin Kingyork
12.8.1 Company Details
12.8.2 Neuromyelitis Optica Drug Product Offered
12.8.3 Tianjin Kingyork Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Tianjin Kingyork News
12.9 Baxter
12.9.1 Company Details
12.9.2 Neuromyelitis Optica Drug Product Offered
12.9.3 Baxter Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Baxter News
12.10 CSL
12.10.1 Company Details
12.10.2 Neuromyelitis Optica Drug Product Offered
12.10.3 CSL Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 CSL News
12.11 Grifols
12.12 Octapharma
12.13 CBOP

13 Research Findings and Conclusion